Skip to main content

Table 5 Effect of current CD4 cell-count on the incidence of cancer.

From: Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence

  Parameter IRR 95% CI p-value
All cancer CD4 [per 100 cells/μl] 0.66 0.57 - 0.76 < 0.001
  HBV co-infection 2.15 1.10 - 4.20 0.024
  Use of HAART 0.28 0.19 - 0.41 < 0.001
  Age [per 10 years] 1.23 1.03 - 1.46 0.023
Infectious related cancer CD4 [per 100 cells/μl] 0.54 0.46 - 0.65 < 0.001
  HBV co-infection 1.99 1.02 - 3.90 0.045
  Use of HAART 0.24 0.16 - 0.37 < 0.001
  Age [per 10 years] 1.10 0.91 - 1.34 0.334
non-infectious related cancer CD4 [per 100 cells/μl] 1.11 0.97 - 1.26 0.125
  HBV co-infection 3.08 0.73 - 13.1 0.129
  Use of HAART 0.42 0.17 - 1.06 0.065
  Age [per 10 years] 1.99 1.52 - 2.61 < 0.001
  1. adjusted for presumed eligible confounders.
  2. IRR incidence rate ratio; CI confidence interval